Contact this trialFirst, we need to learn more about you.
Immunotherapy
CJRB-101 + Pembrolizumab for Advanced Cancer
Recruiting1 awardPhase 1 & 2
Pittsburgh, Pennsylvania
"This trial will take place at different locations in the USA and Republic of Korea. It will test the safety and effectiveness of CJRB-101 combined with pembrolizumab in patients with certain types
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service